This morning diabetes data management company Glooko announced that two soon-to-be released Novo Nordisk connected insulin pens will now be connected to the former’s diasend platform. The connected ...

Novo Nordisk, Eli Lilly & Co. and Sanofi dominate the market for insulin products worldwide, while the much-smaller Biocon is a key player in the copycat segment. The global insulin-pen market is ...

Based on the agreement, Novo Nordisk will be commercializing Mallya in Japan from the first half of 2023. “ Earlier this year, we launched the first ever smart insulin pens* in Japan (NovoPen ...